Varex Imaging $VREX Shares Bought by Rice Hall James & Associates LLC

Rice Hall James & Associates LLC increased its position in Varex Imaging (NASDAQ:VREX) by 19.1% during the fourth quarter, Holdings Channel reports. The fund owned 1,082,964 shares of the company’s stock after purchasing an additional 173,703 shares during the quarter. Rice Hall James & Associates LLC’s holdings in Varex Imaging were worth $12,617,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds have also recently bought and sold shares of the company. Quarry LP acquired a new position in Varex Imaging during the 3rd quarter valued at about $64,000. BNP Paribas Financial Markets increased its stake in shares of Varex Imaging by 18.5% in the second quarter. BNP Paribas Financial Markets now owns 13,045 shares of the company’s stock valued at $113,000 after purchasing an additional 2,036 shares during the period. Aquatic Capital Management LLC bought a new stake in shares of Varex Imaging during the third quarter valued at approximately $117,000. Cerity Partners LLC bought a new stake in shares of Varex Imaging during the second quarter valued at approximately $123,000. Finally, Legato Capital Management LLC acquired a new position in shares of Varex Imaging during the third quarter worth approximately $125,000.

Varex Imaging Stock Performance

Shares of VREX opened at $10.44 on Tuesday. The company has a debt-to-equity ratio of 0.67, a current ratio of 3.20 and a quick ratio of 1.43. The firm’s 50 day moving average is $10.83 and its 200-day moving average is $11.88. Varex Imaging has a 12-month low of $6.76 and a 12-month high of $14.56. The stock has a market capitalization of $439.52 million, a P/E ratio of -5.22 and a beta of 0.91.

Varex Imaging (NASDAQ:VREX) last released its earnings results on Thursday, May 7th. The company reported $0.21 EPS for the quarter, missing the consensus estimate of $0.22 by ($0.01). The business had revenue of $216.00 million for the quarter, compared to analyst estimates of $216.92 million. Varex Imaging had a negative net margin of 9.64% and a positive return on equity of 8.19%. Varex Imaging has set its Q3 2026 guidance at 0.150-0.300 EPS. Equities research analysts anticipate that Varex Imaging will post 0.93 EPS for the current fiscal year.

Insider Activity at Varex Imaging

In other news, Director Jay K. Kunkel sold 4,510 shares of the firm’s stock in a transaction on Friday, March 20th. The stock was sold at an average price of $11.14, for a total transaction of $50,241.40. Following the completion of the sale, the director directly owned 23,450 shares of the company’s stock, valued at $261,233. This trade represents a 16.13% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Company insiders own 4.60% of the company’s stock.

Analyst Upgrades and Downgrades

Several analysts recently commented on VREX shares. Wall Street Zen cut Varex Imaging from a “buy” rating to a “hold” rating in a research report on Saturday, May 9th. Zacks Research upgraded Varex Imaging from a “hold” rating to a “strong-buy” rating in a research report on Monday, April 13th. Finally, Weiss Ratings reissued a “sell (d-)” rating on shares of Varex Imaging in a report on Friday, March 27th. One investment analyst has rated the stock with a Strong Buy rating, two have assigned a Buy rating, one has issued a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $16.17.

About Varex Imaging

Varex Imaging Corporation is a global provider of X-ray imaging components and solutions for the medical, security and industrial markets. The company designs, develops and manufactures a broad range of products that convert X-ray energy into high-resolution digital images. Its portfolio includes X-ray tubes, flat panel detectors, digital sensors, specialty radiographic tubes and related software, all engineered to meet the demanding requirements of original equipment manufacturers (OEMs) in diagnostic imaging, computed tomography (CT), fluoroscopy, mammography, dental radiography and non-destructive testing applications.

The company’s medical imaging offerings support a wide spectrum of clinical modalities, from portable radiography systems to advanced CT scanners, enhancing image quality and dose efficiency for healthcare providers.